Related references
Note: Only part of the references are listed.IDH1/2mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis
Badder Kattih et al.
LEUKEMIA (2021)
Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease
Sarah U. Morton et al.
JAMA CARDIOLOGY (2021)
The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2021)
Cancer-A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism
Daniel Finke et al.
FRONTIERS IN PHYSIOLOGY (2021)
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
Luigia Stefania Stucci et al.
GENES (2021)
A Computational Pipeline to Predict Cardiotoxicity From the Atom to the Rhythm
Pei-Chi Yang et al.
CIRCULATION RESEARCH (2020)
Fatal heart disease among cancer patients
Kelsey C. Stoltzfus et al.
NATURE COMMUNICATIONS (2020)
Dual Transcriptomic and Molecular Machine Learning Predicts all Major Clinical Forms of Drug Cardiotoxicity
Polina Mamoshina et al.
FRONTIERS IN PHARMACOLOGY (2020)
Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients
Yadi Zhou et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Cardiovascular Health during and after Cancer Therapy
Kathryn J. Ruddy et al.
CANCERS (2020)
Spontaneous mutations in the single TTN gene represent high tumor mutation burden
Ji-Hye Oh et al.
NPJ GENOMIC MEDICINE (2020)
Titin-truncating variants are associated with heart failure events in patients with left ventricular non-compaction cardiomyopathy
Shijie Li et al.
CLINICAL CARDIOLOGY (2019)
Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity
Chuipu Cai et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
The giant titin: how to evaluate its role in cardiomyopathies
Amar Azad et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2019)
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
Yimei Feng et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer and heart disease: associations and relations
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic lschemic Heart Failure
Lena Dorsheimer et al.
JAMA CARDIOLOGY (2019)
Increased Cancer Prevalence in Peripartum Cardiomyopathy
Tobias J. Pfeffer et al.
JACC: CARDIOONCOLOGY (2019)
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Peter A. Henriksen
HEART (2018)
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
Soichi Sano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients
Allison L. Cirino et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy
Edward J. Pearson et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
M. Krajinovic et al.
PHARMACOGENOMICS JOURNAL (2016)
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
Folefac Aminkeng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Shared Risk Factors in Cardiovascular Disease and Cancer
Ryan J. Koene et al.
CIRCULATION (2016)
ATM Mutations in Cancer: Therapeutic Implications
Michael Choi et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines
Daniel L. Hertz et al.
PHARMACOGENOMICS (2016)
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
Christof Vulsteke et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Avβ3 integrin: Pathogenetic role in osteotropic tumors
Stefania Stucci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
ATM and ATR as therapeutic targets in cancer
Anika Maria Weber et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
E. Solary et al.
LEUKEMIA (2014)
Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation
Saro H. Armenian et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Impact of Hemochromatosis Gene Mutations on Cardiac Status in Doxorubicin-Treated Survivors of Childhood High-Risk Leukemia
Steven E. Lipshultz et al.
CANCER (2013)
Chemotherapy induced DNA damage response Convergence of drugs and pathways
Derek Woods et al.
CANCER BIOLOGY & THERAPY (2013)
JAK2 Mutation-Related Disease and Thrombosis
Alessandro M. Vannucchi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
Agnes F. Semsei et al.
CELL BIOLOGY INTERNATIONAL (2012)
Targeting JAK2 in the therapy of myeloproliferative neoplasms
Mamatha M. Reddy et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
The ATM protein: The importance of being active
Yosef Shiloh et al.
JOURNAL OF CELL BIOLOGY (2012)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
Rare variants in the ATM gene and risk of breast cancer
David E. Goldgar et al.
BREAST CANCER RESEARCH (2011)
The Giant Protein Titin as an Integrator of Myocyte Signaling Pathways
Wolfgang A. Linke et al.
PHYSIOLOGY (2010)
Up-regulation of myocardial DNA base excision repair activities in experimental heart failure
Arne Yndestad et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy
Virginie Carmignac et al.
ANNALS OF NEUROLOGY (2007)
The giant protein titin - A major player in myocardial mechanics, signaling, and disease
HL Granzier et al.
CIRCULATION RESEARCH (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
